MEDGm GLP-1 Review 2026: Is the $169 Starting Price the Telehealth Weight-Management Deal It First Appears to Be? Costs & Treatment Paths Examined

DOVER, Del., September 9, 2026 (Newswire.com) - Saw the MEDGm ad and want the real numbers before you tap "Get Started"? Here's what the company's own pricing page, terms, and refund policy actually say.

Advertorial. Quick disclosure before you read further: this is a paid advertorial, and a commission is earned if you buy through links in this article. Product claims are attributed to the brand and aren't independently endorsed. MEDGm is a telehealth platform, not a pharmacy or medical practice - it connects you with independent, licensed providers for compounded GLP-1 medication where clinically appropriate. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. This content is promotional and intended for consumer education about a commercially available product. Official site: medgm.org. Details reflect brand materials reviewed in September 2026 - confirm current information before ordering.

MEDGm GLP-1 Program Overview Consumer Research 2026: Researching What the $169 Price Leaves Out (Semaglutide, Tirzepatide, Ozempic, Wegovy, Zepbound)

MEDGm in 50 words: a cash-pay telehealth platform offering compounded GLP-1 injections and tablets, plus a path to brand-name Ozempic®, Wegovy®, and Zepbound®, priced from $169/month. Care comes from OpenLoop Healthcare Partners, PC providers; medication ships from named U.S. pharmacy partners.

You saw an ad for MEDGm. Maybe it was Facebook, maybe Instagram, maybe a short video promising a simple weekly injection or a daily dissolvable tablet. Something caught your eye, and now you're doing exactly what smart buyers do before spending money on a prescription program: checking the details first. Who actually treats you? What does it cost once you're past the "starting at" number? What happens if you want to cancel?

That's what this overview walks through, using MEDGm's own published terms, consent forms, and pricing pages as the source material.

See exactly what MEDGm's $169 price does and doesn't include

What Is MEDGm and Who Is It For?

MEDGm is a telehealth weight-management platform. According to the brand, it connects adults age 18 and older with independent, U.S.-licensed medical providers who evaluate candidates for GLP-1 medication - the same drug class as Ozempic®, Wegovy®, and Zepbound® - and, where clinically appropriate, prescribe either a compounded version or facilitate access to the brand-name product itself.

The brand positions MEDGm for adults who want a structured, provider-supervised weight-loss program without an in-person clinic visit, who are comfortable with a subscription-based cash-pay model, and who meet the clinical eligibility criteria applied during intake. It is not positioned as a substitute for emergency care, and per the brand's own terms, the assessment on the site does not by itself create a provider-patient relationship - that relationship begins only after a licensed provider reviews the case.

MEDGm's on-site FAQ states you're "likely a great candidate" if you're between 18 and 74 years old with a BMI of 20 or higher. That's worth reading carefully alongside MEDGm's own detailed Safety Information page, which describes the clinical indication for compounded semaglutide and tirzepatide as chronic weight management "for people with an initial body mass index (BMI) of 27 kg/m2 or higher." A BMI of 20 falls within the normal, healthy weight range - well below the 27+ threshold the brand's own medication-specific safety document uses. This article doesn't resolve that gap; it's a specific, documented question worth raising directly with a Provider during intake rather than assuming the marketing-page figure applies to your situation.

Buyer takeaway: MEDGm is a facilitation platform, not a pharmacy or medical practice in its own right. The actual prescribing decision sits with a separate, named medical group - covered in the next section - not with MEDGm itself.

How MEDGm's Program Actually Works: The Three Parties Involved

MEDGm's own Telehealth Consent form spells out three distinct parties, and the distinction matters for anyone deciding whether to sign up.

MEDGm, LLC is the platform. Per its Telehealth Consent page, "MEDGm, LLC serves as the patient-facing telehealth platform and is not itself a licensed medical practice." MEDGm's role is administrative and technological: the intake form, the payment processing, the coordination between patient, provider, and pharmacy.

OpenLoop Healthcare Partners, PC and its affiliated entities - referred to in MEDGm's consent materials as "the Practice" - are the licensed medical group. According to the brand's Terms of Use and Telehealth Consent, "all clinical services, diagnoses, and treatments are provided exclusively by Providers employed or contracted by the Practice." Those Providers may be physicians (MD or DO), nurse practitioners, or physician assistants. Which affiliated entity actually handles your care depends on your state - the consent form lists several, including OpenLoop Healthcare Partners California, PC; Colorado, PC; New Jersey Professional Corporation; and Wisconsin, S.C.

One credential note worth flagging: MEDGm's on-site FAQ separately describes its Providers as "board-certified," a specific qualification not used anywhere in the Terms of Use or Telehealth Consent, which describe Providers only as licensed physicians, nurse practitioners, or physician assistants without a stated board-certification requirement. This article doesn't independently verify board-certification status and isn't asserting it either way - if that credential matters to you, confirm it directly during intake.

The Pharmacy Partners are the third party. MEDGm's Terms of Use name four independently owned and operated compounding pharmacies that fulfill Provider-issued prescriptions: RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Medicine (Bellmore, NY), and Triad Rx (Daphne, AL). The brand states this list may change over time.

Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed. MEDGm does not prescribe, and per the brand's own language, its role is limited to facilitating access to the platform and the Practice's providers.

Buyer takeaway: MEDGm's Terms say MEDGm itself isn't responsible for a Provider's acts or omissions, and separately point to the Practice and its Providers as the ones responsible for clinical care. That's a summary of MEDGm's own contract language - it isn't this article's independent legal conclusion about who'd be liable in any actual dispute.

Check your MEDGm eligibility in 2 minutes

GLP-1 Injections vs. GLP-1 Tablets vs. Brand-Name Access: What's the Difference?

MEDGm's product page lists four distinct paths, each with its own starting price and positioning. This is brand-stated information, not an independent lab comparison - here's the quick version:

• Compounded GLP-1 Injections - "one simple injection per week," starting at $169. Compounded, not a specific FDA-approved brand.

• Compounded GLP-1 Tablets - "one dissolvable tablet per day," starting at $239. Also compounded, not the brand-name oral product.

• Zepbound® Injection - $99 membership plus medication cost. FDA-approved for weight management; MEDGm is not affiliated with, endorsed by, or sponsored by the manufacturer.

• Wegovy® Pill or Pen - $99 membership plus medication cost. Same FDA-approval and non-affiliation notes as above.

• Ozempic® Injection - $171 membership plus medication cost. FDA-approved for type 2 diabetes; "may be prescribed for weight loss" off-label, at the Provider's judgment.

The brand notes "availability is subject to change" for all three brand-name paths. MEDGm's Terms of Use also state directly that "off-label use is a legally permitted and common medical practice," and that off-label prescribing "is not experimental and is made in the Provider's professional judgment" - worth knowing if a provider recommends Ozempic® specifically for weight management rather than diabetes.

Buyer takeaway: The $99 and $171 "membership" tiers for brand-name products are separate from the medication cost itself - the brand's pricing page doesn't show an all-in total for those paths, only "membership + medication cost."

MEDGm Semaglutide vs. Tirzepatide: What Can a Patient Actually Choose?

Semaglutide and tirzepatide are the two active-ingredient families behind MEDGm's compounded and brand-name pathways alike - semaglutide is the active ingredient in Ozempic® and Wegovy®, while tirzepatide is the active ingredient in Zepbound® and Mounjaro®. This article does not make a clinical recommendation between the two, and neither does MEDGm's own public-facing pricing page: the site lists treatment paths, not a molecule-selection tool.

Per MEDGm's Terms of Use, a patient does not self-select the specific formulation. An OpenLoop Healthcare Partners, PC provider determines, based on intake information and clinical judgment, which product and dosage is appropriate - and the Terms explicitly reserve the Provider's ability to recommend "a different formulation, dosage, or product (including a different molecule such as tirzepatide vs. semaglutide)" than what a patient may have expected going in.

Buyer takeaway: Anyone with a preference between semaglutide-based and tirzepatide-based treatment should raise it directly during intake - MEDGm's own Terms make clear the final decision sits with the Provider, not the patient's initial selection on the pricing page.

What MEDGm's Own Consent Materials Disclose About GLP-1 Risks

Because MEDGm publishes a detailed Consent to Compounded Medication as part of its Terms of Use, a good amount of the risk picture is available directly from the brand rather than requiring outside research. This section summarizes what MEDGm's own documents say - it is brand-disclosed information, not independent clinical guidance, and it does not replace a conversation with a Provider.

Per the brand's Terms, potential adverse effects associated with the GLP-1 drug class include:

• Nausea, vomiting, diarrhea, and constipation

• Dehydration and hypoglycemia

• Gallbladder disease and pancreatitis

• Kidney injury

• Allergic reactions and injection-site reactions

The Terms also disclose what the brand describes as "the FDA boxed-warning risk of medullary thyroid carcinoma for the drug class." A boxed warning is the FDA's most serious drug-labeling warning category. This article doesn't independently verify which specific product labels carry it beyond what the brand states - that's a question for your Provider.

The brand's compounded-medication consent also states that compounded products "may differ in appearance, color, viscosity, packaging, concentration, excipients, and administration instructions" from the FDA-approved brand-name versions, and are "not therapeutically equivalent to, and are not substitutes for, FDA-approved products." That is the brand's own characterization, not a third-party lab finding.

Buyer takeaway: This is not a section to skim. MEDGm asks patients to read and consent to this exact information before receiving compounded medication - reading it here first, before paying, costs nothing and may raise questions worth asking a Provider directly.

Compounded Medication vs. Brand-Name Medication: What the Terms of Use Say

This is the single most-repeated disclosure across MEDGm's site, and it's worth its own section because it directly affects what a buyer receives.

Compounded medications, per MEDGm's Terms, "are not approved by the U.S. Food and Drug Administration." The FDA does not review compounded medications for safety, efficacy, or quality before they're dispensed. MEDGm's Pharmacy Partners are described as state-licensed 503A or FDA-registered 503B compounding facilities. State pharmacy licensure or registration as an FDA outsourcing facility under section 503B of the Federal Food, Drug, and Cosmetic Act should not be confused with FDA approval of a finished drug. Compounded drugs generally do not undergo FDA premarket review for safety, effectiveness, or quality.

The brand is explicit that individuals "may receive medications that look different from those shown on the website," and that MEDGm itself "does not produce compounded medications" - that is the Pharmacy Partners' role.

For the brand-name path (Ozempic®, Wegovy®, Zepbound®), the medication is the FDA-approved product itself, subject to standard availability constraints the brand flags directly on its pricing page ("availability is subject to change").

Buyer takeaway: Whether compounded or brand-name medication is the better fit is a clinical question for the Provider, not something this article can determine - but knowing the regulatory distinction going in means asking the right question during intake.

The Changing Regulatory Landscape for Compounded GLP-1 Medications

This section reflects FDA's own published materials as of September 2026 and is included because the regulatory ground under mass-market compounded GLP-1 medication has shifted significantly and continues to move.

Semaglutide and tirzepatide were each added to FDA's drug shortage list in 2022. Shortage status had been an important statutory factor permitting certain compounding activity that otherwise faces restrictions on making products that are essentially copies of commercially available or FDA-approved drugs. Per industry and legal reporting, FDA resolved the semaglutide shortage in early 2025 and the tirzepatide shortage on a separate timeline in 2024-2025 - each on its own determination, not a single shared timeline - closing the shortage-based basis that had supported large-scale compounding of both drugs.

Separately, on April 30, 2026, FDA announced it is proposing to exclude semaglutide, tirzepatide, and liraglutide from the "503B Bulks List" - the list of active ingredients that large-scale outsourcing-facility compounders are permitted to use under section 503B of the Federal Food, Drug, and Cosmetic Act. Per FDA's own announcement, the agency did not identify a clinical need for outsourcing facilities to compound these three drugs from bulk substances absent a shortage. The public comment period on this proposal closed in mid-2026, and as of this article's writing, FDA has not yet issued a final determination - this remains a proposed rule, not a finalized one.

FDA's own consumer-facing guidance on unapproved GLP-1 drugs, updated September 1, 2026, says compounded drugs should generally be used only when your medical need can't be met by an FDA-approved drug. It also lists specific telehealth red flags to watch for:

• A company claiming its compounded drug is the same as an FDA-approved drug

• Prices that seem too good to be true

• No screening and prescription from a licensed doctor before you get medicine

The same FDA page discloses that, as of May 31, 2026, the agency had received 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide. FDA also cautions that an adverse-event report does not by itself establish that the compounded drug caused the event, because other factors may have contributed. The same page separately flags cold-chain shipping and salt-form substitution - semaglutide sodium or acetate, which the agency notes are different active ingredients than the approved drug - as areas of concern.

None of this is a statement that MEDGm's specific Pharmacy Partners are out of compliance - MEDGm's Terms describe those partners as state-licensed 503A or FDA-registered 503B facilities. FDA's April 2026 proposal specifically concerns the 503B Bulks List and should not be treated as a blanket determination about every patient-specific compounding circumstance under section 503A. Both 503A and 503B compounding remain subject to separate statutory requirements and restrictions. What the proposal does mean is that the regulatory footing under any 503B-sourced portion of MEDGm's compounded pathways is actively in motion, and availability, pricing, or the specific compounding pathway used could change with comparatively little notice if FDA finalizes its proposal. Readers can review FDA's current guidance on unapproved GLP-1 drugs directly for the latest status.

Buyer takeaway: If the compounded pathway's continued availability matters to your decision, this is a live regulatory question, not a settled one - ask MEDGm directly about contingency plans before committing to a multi-month bundle.

See which MEDGm treatment paths are available in your state

LegitScript Badge and the Pharmacy Partner Network

MEDGm displays a LegitScript certification seal that links readers toward LegitScript verification. LegitScript operates a public website-certification lookup that consumers can use to check the current certification status of healthcare websites.

The four named Pharmacy Partners - RedRock Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx - are described by MEDGm as "independently owned and operated" and "solely responsible for compounding, labeling, dispensing, and shipping of prescription medications in accordance with applicable federal and state law and the Provider's prescription." MEDGm's Terms state this list "may change from time to time." That means the specific pharmacy filling your order might not be named at checkout.

Buyer takeaway: A LegitScript badge and named pharmacy partners are verifiable, brand-disclosed credibility signals - worth confirming directly with the brand if a specific pharmacy's licensing status matters to your decision.

Is MEDGm Legitimate? What This Article Could Independently Verify

Rather than answer this with a yes-or-no verdict, here's the objective checklist this article was able to confirm directly against MEDGm's own published pages, so readers can judge for themselves:

• Publicly identifiable platform entity: confirmed - MEDGm, LLC, a Delaware LLC with a registered office in Dover, DE.

• Named licensed medical group: confirmed - OpenLoop Healthcare Partners, PC and its affiliated state entities, an independently verifiable telehealth clinician network.

• Named pharmacy partners: confirmed - four specific compounding pharmacies, with the brand's own caveat that the list may change.

• Public Terms of Use, Refund Policy, and Telehealth Consent: confirmed - all three are published and detailed.

• Third-party certification badge: confirmed displayed - MEDGm displays a LegitScript seal; current certification status can be checked independently through LegitScript's lookup tool.

• Independent, third-party-audited review data: not found on the pages reviewed - testimonials are brand-published and self-reported, with no visible star rating or review-count platform.

These are transparency and verification signals, not a guarantee of treatment outcome, and not an endorsement of MEDGm by this publication.

What MEDGm Discloses About AI Use in Your Care

MEDGm's Telehealth Consent form includes a detailed section on artificial intelligence, worth understanding before your first visit. Per the brand's consent language, a visit through the Practice "may involve the use of artificial intelligence (AI) technologies for various purposes, including but not limited to transcription of conversations, analysis of medical information, clinical decision support, quality assurance, and improvement of telehealth services." That processing can happen in real time during your visit or afterward, and can include your voice, image, and medical information.

MEDGm's consent language says "AI tools are intended to support, not replace, the professional judgment of my Provider," and that the Provider "will review any AI-assisted outputs before making clinical decisions." You also retain, per the brand's own consent form, the right to ask questions about how AI is used in your care and to request that it not be used in certain aspects of your treatment, where feasible.

Separately, MEDGm's Terms disclose that some site content - images, videos, illustrations, product mockups, background copy, lifestyle imagery - "may be created, enhanced, or assisted using artificial intelligence tools." That content is for "illustrative or aesthetic purposes" and doesn't represent a specific individual, patient, or clinical outcome unless labeled otherwise.

Buyer takeaway: If AI-assisted transcription or clinical support tools matter to your comfort level with a telehealth visit, MEDGm's own consent materials give you specific language to ask your Provider about before your appointment, including the right to request AI not be used in parts of your care.

How MEDGm Handles Your Health Information

MEDGm's Terms of Use describe a specific privacy structure worth understanding before submitting medical history through the intake form. Per the brand, MEDGm itself "is not itself a HIPAA 'Covered Entity'" - that status belongs to the MEDGm Affiliated P.C.s (OpenLoop Healthcare Partners, PC and its affiliates) and their Providers. To the extent MEDGm receives or maintains Protected Health Information on behalf of those P.C.s, it acts as a HIPAA "Business Associate" and states it will comply with applicable HIPAA obligations.

The brand's Terms also flag a practical risk: any communication of Protected Health Information through unencrypted email, SMS, or voice "presents a risk of unauthorized access or disclosure," and by choosing those communication channels, a patient accepts that risk. MEDGm's consent materials separately note that a patient's information may be transmitted to the Practice, Providers, Pharmacy Partners, laboratories, payment processors, and shipping carriers as necessary to deliver the service.

Buyer takeaway: If a patient prefers not to receive text or email communications that could contain health-related information, MEDGm's Terms state that consent to electronic communications can be withdrawn by contacting info@medgm.org, though withdrawal may limit use of the service.

How to Get Started With MEDGm: Step by Step

According to MEDGm's own "How It Works" page, the process runs in three stated steps:

1. Complete the intake. A medical questionnaire covering health history and weight-loss goals; the brand describes it as taking "less than 2 minutes."

2. Get prescribed. Once a Provider affiliated with OpenLoop Healthcare Partners, PC reviews the intake and determines clinical eligibility, a prescription may be issued - not guaranteed, and dependent on the Provider's independent clinical judgment.

3. Receive your prescription. Medication ships to your address through the assigned Pharmacy Partner.

The brand separately notes that telehealth regulations vary by state, and some states require a live video or phone consultation before a provider can prescribe - so the exact process can differ depending on where you live. MEDGm's Terms also note that after an initial synchronous review, refill reviews may happen asynchronously unless you request, or the Provider requires, a live visit.

Buyer takeaway: The "less than 2 minutes" figure describes the intake form only, not the full time to prescription - that depends on Provider review and, in some states, a required live consultation.

Begin the MEDGm intake questionnaire

What's Included in Your MEDGm Program Membership

Per MEDGm's Terms of Use, the Program Membership Fee is described as covering "both medication shipments and ongoing access to Providers and the MEDGm platform" - and the brand states plainly that charges continue "even if, in a given period, you do not complete a required refill form or do not receive a medication shipment." That's an important detail: the subscription fee is not solely a per-shipment charge.

The brand's Refund Policy FAQ describes the Subscription Service price as potentially including:

• Consultations, both live and via electronic form submissions and reviews by a healthcare provider

• Laboratory services or other healthcare services

• A 24/7 patient support line

• Other services to support your medical journey

The brand doesn't itemize which of these apply to every plan tier - though its separate on-site FAQ describes the $169 starting price specifically as "all-inclusive" of consultation, a metabolic report, labs, and medication, which is a more concrete claim worth confirming at your own dose and plan.

Buyer takeaway: If a Provider recommends a different formulation or dosage mid-subscription - say, switching from semaglutide to tirzepatide - MEDGm's Terms state that continued enrollment constitutes consent to that change, and billing continues regardless.

MEDGm Pricing: What You'll Actually Pay

Here's the number that matters most: the $99 and $171 "membership" prices for brand-name Ozempic®, Wegovy®, and Zepbound® aren't your total cost - the actual medication charge isn't shown anywhere on MEDGm's pricing page. Here's the full breakdown, reflecting MEDGm's official product page as reviewed for this article. Prices and availability are subject to change - confirm current figures directly on the official site before ordering.

• Compounded GLP-1 Injections: starting at $169

• Compounded GLP-1 Tablets: starting at $239

• Zepbound® Injection: $99 membership + medication cost

• Wegovy® Pill or Pen: $99 membership + medication cost

• Ozempic® Injection: $171 membership + medication cost

The Program Membership Fee is billed upfront for the entire Subscription Term at enrollment. Per MEDGm's Terms, patients can choose a monthly term or a multi-month bundle (3, 6, or 12 months); billing renews automatically on the day after the current term ends unless canceled, and the brand states billing or shipment may occur up to 10 days before the formal renewal date "to prevent gaps in treatment." Prices shown are quoted in U.S. dollars and don't include applicable sales tax, per the Terms.

What the $169 starting price does and doesn't mean: MEDGm's $169 figure is a starting price for the compounded GLP-1 injection pathway specifically. It is not the universal cost of every MEDGm treatment, does not reflect a specific dosage or titration schedule, and does not apply to the brand-name Ozempic®, Wegovy®, or Zepbound® pathways, which use a separate membership-plus-medication-cost structure. MEDGm's on-site FAQ separately describes the $169 starting price as "all-inclusive," covering the clinical consultation, a personalized metabolic report, lab work, and the medication itself - a level of detail not repeated on the pricing section shown earlier in this article, so it's worth confirming exactly what's bundled at your specific dose and plan. MEDGm's own site also separately advertises "no hidden fees" as part of its guarantee messaging; that claim is easiest to evaluate for yourself once you have the specific medication cost in hand, since the brand-name pathways don't display an all-in total on the pricing page itself.

Buyer takeaway: The homepage figures are "starting at" prices for the compounded paths - the brand-name paths list a separate membership fee plus an unstated medication cost, so the true monthly total for Ozempic®, Wegovy®, or Zepbound® through MEDGm isn't fully disclosed on the pricing page itself.

See the medication cost MEDGm's membership price leaves out

Does Insurance, HSA, or FSA Cover MEDGm?

MEDGm's Terms state plainly that "the Company is cash-pay only and does not accept, bill, or coordinate benefits with health insurance, Medicare, or Medicaid." The Company also does not guarantee that amounts paid are eligible for reimbursement by insurance, HSA, FSA, or any other benefit account.

The brand's homepage separately advertises "HSA/FSA accepted" alongside the note that "reimbursement eligibility depends on your plan and may require medical consultation." Read together, this means MEDGm can likely process an HSA or FSA card as a payment method, but whether the specific charge is ultimately reimbursable under a given plan is between the patient and their plan administrator - not something MEDGm confirms or guarantees.

Buyer takeaway: Insurance coverage, if any, depends on the buyer's specific plan and is not confirmed by this article or by MEDGm itself. Check directly with your HSA/FSA administrator before assuming reimbursement.

MEDGm Reviews and Testimonials: What the Website Actually Shows

MEDGm's site displays patient testimonials describing individual weight-loss experiences. Per the brand's own disclosure, "all claims and benefits on this website refer to self-reported data from GLP-1 clients," collected via the initial medical questionnaire and updated every three to four weeks by the client. The brand states results "may vary and depend on individual adherence, provider guidance, and lifestyle changes."

It's worth being direct about what that disclosure does and doesn't cover: MEDGm's pages did not, at the time of this review, publish data on what a typical or average patient using the program can expect to lose, over what timeframe, or with what consistency. The featured testimonials describe individual, self-reported outcomes - they are not a substitute for average-result data, and a "results may vary" disclaimer does not by itself establish what an average user should realistically expect.

MEDGm's site also discloses that, "for patient privacy, images representing those testimonials may use models" - meaning the photos shown alongside a testimonial may not depict the actual person quoted, even though the brand states the testimonials themselves come from real MEDGm patients. No independent third-party review platform, star rating, or review count is displayed on the pages reviewed for this article - these are brand-published, self-reported figures, not an independently audited rating.

Buyer takeaway: Treat the featured testimonials as illustrative individual stories, not as a benchmark for what you personally should expect - and if a typical-result figure matters to your decision, that's a fair question to ask MEDGm directly, since it isn't published on the pages reviewed here.

The MEDGm Cancellation and Refund Policy, Explained

MEDGm publishes a detailed cancellation and refund policy, and it's worth reading in full before enrolling - MEDGm's default position is that the Program Membership Fee is non-refundable, with specific, narrow exceptions:

• Medical disqualification: if a licensed provider disqualifies you on medical grounds, MEDGm states a refund will be issued for the portion of the term that can no longer be delivered - a full refund if it happens before the first shipment, or a pro-rata refund for unshipped months if it happens partway through a multi-month bundle. The homepage separately advertises "100% refund if our licensed provider determines you don't qualify," which appears consistent with this provision. Worth noting: MEDGm's on-site FAQ describes this refund as issued "immediately," while the Refund Policy's own processing terms state approved refunds are issued to your original payment method "within thirty (30) days of approval." If the timing matters to you, the 30-day figure is the one written into the actual policy document.

• Voluntary cancellation, monthly plan: no refund for the month cancellation occurs or any prior month; service continues through the end of the paid month.

• Voluntary cancellation, multi-month bundle: no refund, partial or otherwise, for 3-, 6-, or 12-month bundles canceled before the term ends - but you keep receiving remaining scheduled shipments through the end of the paid term.

• Cancellation window: to stop automatic renewal, MEDGm requires notice at least 72 hours before the next billing date, by email to support@medgm.org or through the member portal.

• Dispensed medication: federal law generally prohibits pharmacies from accepting returned dispensed prescription medication, so once a shipment goes out, it's non-returnable and non-refundable regardless of the reason.

• Damaged or incorrect items: eligible for replacement, not a monetary refund, if you contact support with evidence of the issue.

Buyer takeaway: Read this policy as "non-refundable by default, refundable only if a provider medically disqualifies you." That's the operative rule if you're considering a multi-month bundle rather than the monthly plan.

See MEDGm's exact cancellation window before you're billed again

Who May Find MEDGm's Program Structure Relevant?

Based on what MEDGm publishes, its program structure tends to line up with people who want a cash-pay telehealth option, are fine with paying for a subscription term upfront, and understand that the actual medication and clinical eligibility get decided by a licensed Provider, not chosen off the pricing page.

Per MEDGm's Terms of Use, formal eligibility to use the service requires:

• Being at least 18 years old

• Having full legal capacity to enter a binding contract

• Not being barred from receiving the service under applicable law

• Not appearing on any U.S. government list of prohibited or restricted parties

• Being located in the United States

The service is not designed to address medical emergencies - if you're experiencing one, call 911 or go to the nearest emergency room rather than using the platform.

The structure tends to line up less well for people who need insurance to cover the cost, want a guarantee they'll get a specific brand-name drug, or aren't comfortable with the subscription terms described earlier in this article.

Whether any GLP-1 medication is medically appropriate for an individual is a clinical determination for the prescribing Provider.

Buyer takeaway: This is a two-sided read of MEDGm's own disclosed terms, not a recommendation - the right fit depends on your specific health history, state of residence, and budget, which is exactly what the intake questionnaire and Provider consultation are designed to sort out.

How MEDGm Compares to Other GLP-1 Telehealth Options

This article does not name or rank specific competing platforms, since doing so without an apples-to-apples audit of each one's own terms would be an unsupported claim. Instead, here's the comparison framework worth applying to MEDGm or any alternative under consideration:

• Who is the licensed medical group actually writing the prescription, and can you find its legal name?

• Who compounds and dispenses the medication, and are the pharmacies named?

• Is the medication compounded or FDA-approved brand-name, and does the platform say so plainly?

• What is the total, medication-inclusive monthly cost - not just the starting or membership price?

• Are dosage increases or formulation changes priced differently, or billed the same?

• What is the exact cancellation deadline, and is it stated in hours or days?

• What happens financially if a provider medically disqualifies you after payment?

• Does the platform bill insurance, or is it cash-pay only?

• Which states does the platform actually support, versus which it merely claims to serve?

Buyer takeaway: Applying these same nine questions to MEDGm and to any competing platform gives a fair, apples-to-apples basis for comparison - far more useful than an unsubstantiated "better than" claim from either side.

State-Specific Consumer Protections for Weight-Loss Programs

Two states require MEDGm to provide a specific consumer-rights disclosure to weight-loss patients, and both are published directly in the brand's Telehealth Consent form. Patients in these states have documented rights worth knowing about even before signing up.

Florida patients prescribed GLP-1 medication for weight loss are provided with a Weight-Loss Consumer Bill of Rights under Florida's law, Fla. Stat. §501.0575, including a specific warning: rapid weight loss - defined as more than 1.5 to 2 pounds per week, or more than 1 percent of body weight per week after the second week of a program - "may cause serious health problems." It also spells out your rights. You can:

• Ask about the program's potential health risks

• Receive an itemized price statement covering any extra products or lab tests

• Know the program's actual or estimated duration

• Know the name and qualifications of any dietitian or nutritionist who reviewed the program

New York patients receive a similar Weight-Loss Consumer Bill of Rights under N.Y. Gen. Bus. Law §642. You can:

• Ask about health risks and program components

• Know the full price of treatment, including extras

• Know the recommended program duration

Buyer takeaway: These are legally mandated disclosures, not MEDGm-specific marketing - if you live in Florida or New York, you're entitled to this information as a matter of state law, and MEDGm's consent form confirms it provides it.

Things to Verify Before You Order From MEDGm

MEDGm's public pages answer most of the core questions, but a handful of specifics are determined only after intake or aren't fully itemized on the pages reviewed for this article. Confirm these directly with MEDGm or during your consultation before paying:

1. Total medication cost for brand-name products. The $99 (Zepbound®/Wegovy®) and $171 (Ozempic®) figures are membership fees only; the medication cost itself isn't listed on the pricing page reviewed for this article.

2. Your specific dosage and formulation. Per the brand, your Provider determines the specific product, dosage, and formulation - including whether semaglutide or tirzepatide is clinically appropriate - and you don't select it upfront.

3. Whether you meet the medication's actual clinical indication. MEDGm's FAQ cites a BMI of 20+ as likely qualifying, while its own Safety Information page states the compounded medications are indicated for a BMI of 27 or higher. Ask your Provider directly which threshold applies to your evaluation.

4. State-specific availability and consultation requirements. The brand states some states require a live video or phone visit before prescribing, and not all services or medications are available everywhere.

5. Which Pharmacy Partner fulfills your order. The brand names four partners but doesn't disclose which one is assigned to a given order in advance, and states the list may change.

6. HSA/FSA reimbursement for your specific plan. MEDGm accepts these payment methods but doesn't confirm or guarantee reimbursement eligibility, which depends on your plan administrator.

Buyer takeaway: These details aren't fully determined by the public-facing pages and should be confirmed before enrollment.

Get the pricing answers MEDGm's page doesn't list

MEDGm Fast Facts

• Platform entity: MEDGm, LLC (Delaware limited liability company)

• Registered office: 8 The Green, Suite R, Dover, DE 19901

• Licensed medical group: OpenLoop Healthcare Partners, PC and affiliated state entities

• Pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Medicine, Triad Rx

• GLP-1 Injections (compounded): starting at $169

• GLP-1 Tablets (compounded): starting at $239

• Zepbound® Injection: $99 membership + medication cost

• Wegovy® Pill or Pen: $99 membership + medication cost

• Ozempic® Injection: $171 membership + medication cost

• Billing model: cash-pay only; no insurance, Medicare, or Medicaid billing

• Subscription terms: monthly, 3-month, 6-month, or 12-month bundles

• Cancellation notice required: at least 72 hours before the next billing date

• Refund eligibility: medical disqualification only (full or pro-rata, depending on shipment status)

• Minimum age: 18

• Certification-related badge displayed: LegitScript seal

• Customer support: support@medgm.org / +1 (214) 667-2145

• Service area: all 50 U.S. states plus Washington, D.C. (availability varies by state)

Quick Answers About MEDGm

Is MEDGm legitimate? MEDGm displays a LegitScript certification seal, names its licensed medical group (OpenLoop Healthcare Partners, PC) and four pharmacy partners, and publishes detailed Terms of Use and consent forms - standard transparency markers, though this article does not independently verify clinical outcomes.

Does MEDGm bill health insurance for its program? No. MEDGm's Terms describe the Company as cash-pay only and state that MEDGm does not accept, bill, or coordinate health-insurance, Medicare, or Medicaid benefits. HSA/FSA cards may be accepted at checkout, but reimbursement eligibility depends on the buyer's individual plan and is not guaranteed by MEDGm.

Can I get brand-name Ozempic® through MEDGm? MEDGm lists an Ozempic® Injection option at $171 in membership fees plus a separate medication cost, with availability "subject to change." Ozempic® is FDA-approved for type 2 diabetes and, per MEDGm, may be prescribed off-label for weight loss.

How do I cancel MEDGm? Email support@medgm.org or use the cancellation function in the member portal at least 72 hours before the next billing date. Per MEDGm's Refund Policy, the current term's Program Membership Fee is non-refundable once billed, with the sole exception being medical disqualification determined directly by a licensed provider.

Is MEDGm FDA-approved? That's not quite the right question - FDA approval applies to specific drugs, not a telehealth platform. MEDGm's brand-name pathways (Ozempic®, Wegovy®, Zepbound®) use FDA-approved drugs; its compounded pathways use compounded medication, which is not FDA-approved.

Frequently Asked Questions About MEDGm

How much does the MEDGm program cost?

Pricing starts at $169 per month for compounded GLP-1 injections and $239 per month for compounded GLP-1 tablets, per MEDGm's official pricing page reviewed for this article. Brand-name Ozempic®, Wegovy®, and Zepbound® options are listed separately at $99 to $171 in membership fees plus an additional, unlisted medication cost that isn't itemized on the public pricing page. All figures are billed upfront for the Subscription Term selected - either monthly or a 3-, 6-, or 12-month bundle - and are explicitly subject to change per the brand's Terms of Use, so confirm current pricing directly on the official site before ordering anything.

What happens if I pay but the licensed clinician determines I don't qualify?

Per MEDGm's Cancellation and Refund Policy, a medical disqualification determined by the licensed provider triggers a refund: a full refund of the current subscription term if disqualification happens before the first medication shipment goes out, or a pro-rata refund covering only the unshipped months if it happens partway through a multi-month bundle that has already shipped some medication. This medical-disqualification carve-out is the primary and, per the brand's own policy language, essentially the only exception to MEDGm's otherwise strictly non-refundable subscription structure, so it's worth understanding clearly before enrolling.

Will MEDGm work for me?

This article cannot answer that question directly - whether MEDGm's program is effective for a given person depends on individual health history, adherence, and a licensed provider's independent clinical judgment, none of which MEDGm's own Terms guarantee will result in a prescription or a specific outcome. The brand's published testimonials describe self-reported weight-loss results that, per MEDGm's own disclosure, "may vary and depend on individual adherence, provider guidance, and lifestyle changes," and the brand states explicitly that no particular clinical outcome or rate of weight loss is guaranteed to any patient.

How does MEDGm's medication delivery work?

Once an OpenLoop Healthcare Partners, PC provider issues a prescription, one of MEDGm's four named Pharmacy Partners - RedRock Pharmacy, Health Warehouse, Precision Medicine, or Triad Rx - compounds, labels, and ships the medication directly to you, per the brand's Terms of Use. MEDGm's on-site FAQ states your first shipment goes out within 48 hours of your initial purchase, with subsequent shipments arriving automatically every four weeks according to your chosen plan. That timeline comes from the FAQ rather than a separate, itemized shipping policy - no dedicated shipping page with carrier details was located separately from the Terms of Use and pricing pages reviewed for this article, so confirm current delivery windows directly with the brand if timing matters to your decision.

Do I get real medical support after I start MEDGm?

Per the brand's own Terms, ongoing access to Providers is included as part of the Program Membership Fee, with an initial synchronous clinical review followed by refill reviews that may be handled asynchronously unless a patient requests, or a Provider's judgment requires, a live follow-up visit. MEDGm's Refund Policy FAQ also references a potential "24/7 patient support line" as part of what the Subscription Service may include, though the brand does not itemize which specific support features apply to every plan tier, so confirming what's included at your chosen tier during intake is worthwhile.

Why choose MEDGm instead of another GLP-1 telehealth provider?

MEDGm's own on-site FAQ poses this exact question, but the brand's public pages don't provide a direct, named comparison against competing platforms, and this article does not evaluate, rank, or make claims about any other GLP-1 telehealth service. What can be confirmed independently from MEDGm's own materials is its specific three-party structure: a named platform (MEDGm, LLC), a named licensed medical group (OpenLoop Healthcare Partners, PC and its affiliates), and named pharmacy partners - a level of specific, checkable disclosure worth comparing against any alternative platform you're considering before enrolling.

Is MEDGm's compounded medication the same as brand-name Ozempic®, Wegovy®, or Zepbound®?

No, and MEDGm's own Consent to Compounded Medication is explicit on this point: compounded products "may differ in appearance, color, viscosity, packaging, concentration, excipients, and administration instructions" from the FDA-approved brand-name versions. The brand describes them as "not therapeutically equivalent to, and are not substitutes for, FDA-approved products." Compounded medications generally aren't FDA-approved and aren't reviewed by the FDA for safety, effectiveness, or quality before being marketed or dispensed - a distinction worth understanding no matter which telehealth platform you're considering.

Who actually prescribes the medication at MEDGm?

OpenLoop Healthcare Partners, PC and its affiliated state-specific entities - collectively referred to in MEDGm's own consent materials as "the Practice" - employ or contract the licensed Providers, including physicians, nurse practitioners, and physician assistants, who make all clinical decisions independently. MEDGm, LLC functions only as the patient-facing technology platform and, per its own Terms of Use, explicitly states that it does not practice medicine, does not employ or control any Provider's clinical judgment, and does not itself offer any diagnosis or treatment to patients.

What are the side effects of GLP-1 medication through MEDGm?

MEDGm's own Terms of Use disclose a specific list of potential adverse effects associated with the GLP-1 drug class, including nausea, vomiting, diarrhea, constipation, dehydration, hypoglycemia, gallbladder disease, pancreatitis, kidney injury, allergic reactions, and injection-site reactions, along with what the brand describes as an FDA boxed-warning risk of medullary thyroid carcinoma associated with the broader drug class. This is brand-disclosed information intended for general awareness, not individualized medical guidance, and any patient with specific risk factors or concerns should raise them directly with their assigned Provider before starting treatment.

Can I cancel MEDGm at any time?

Yes - per the brand's Terms of Use, a patient can request cancellation at any time and for any reason, but to avoid being billed for the next Subscription Term, MEDGm requires notice at least 72 hours before the next billing date, submitted either by email to support@medgm.org or through the cancellation function in the member portal. Canceling does not retroactively refund the current paid term in most cases; the only stated exception, per MEDGm's Refund Policy, is when a licensed provider medically disqualifies the patient partway through their term.

Does MEDGm offer a 3-month, 6-month, or 12-month bundle discount?

MEDGm's Terms of Use confirm that multi-month bundles are available in 3-, 6-, and 12-month terms, billed upfront in full at the time of enrollment rather than month by month, but the pricing page reviewed for this article does not display a specific per-month discount rate for selecting a longer bundle over the standard monthly plan. Anyone deciding between a monthly subscription and a multi-month bundle should confirm the exact bundle pricing directly with MEDGm and weigh it against the bundle's considerably stricter, non-refundable cancellation terms described earlier in this article.

Compare MEDGm's five treatment paths side by side

Is MEDGm available in my state?

MEDGm states on its Terms of Use page that it offers services in all 50 U.S. states plus Washington, D.C., but immediately qualifies that by noting "some services may not be available in every state" and that availability is "subject to change at any time without notice." The brand places the responsibility squarely on the patient to verify availability in their specific state before initiating a consultation or completing a purchase, since certain states also require a live video or phone visit before a Provider can prescribe.

What happens to my medication if I switch from semaglutide to tirzepatide mid-subscription?

Per MEDGm's Terms of Use, if an OpenLoop Healthcare Partners, PC provider decides a different formulation, dosage, or product - including switching between molecules like semaglutide and tirzepatide - is clinically more appropriate, staying enrolled counts as your consent to that change, and your subscription and Program Membership Fee charges continue either way. The Terms don't say a switch always keeps the price identical, so if pricing matters to you, confirm it directly with MEDGm before agreeing to a formulation change.

Does MEDGm guarantee weight-loss results?

No. MEDGm's Terms say plainly that "there is no guarantee of results or effectiveness of any treatment or care plan provided." Neither MEDGm nor any affiliated medical group "guarantees any particular clinical outcome, any specific amount or rate of weight loss, any specific symptom improvement, or that any prescription will be issued." The testimonials on MEDGm's site reflect self-reported, individual results that the brand itself describes as not typical, and that depend on your own adherence, your provider's guidance, and your lifestyle.

What if my medication arrives damaged or incorrect?

Per MEDGm's Cancellation and Refund Policy, damaged or incorrect items should be reported immediately to support@medgm.org along with evidence of the problem, at which point the brand states it will coordinate directly with the applicable Pharmacy Partner to arrange a replacement. It's worth noting this results in a physical replacement of the item rather than a monetary refund, and submitting a damage claim does not by itself cancel or otherwise modify the underlying subscription term a patient is enrolled in.

Is a MEDGm telehealth visit the same as an in-person doctor visit?

No, and MEDGm's own Telehealth Consent form is explicit about the practical differences: during a telehealth visit, the Provider "will not be present in the room with me," there is no in-person physical examination performed, and the Provider "may not have access to a complete copy of my medical records" unless the patient has taken steps to share them. The brand's consent language acknowledges this limitation could, in some cases, contribute to negative health outcomes such as a missed adverse drug interaction, while also confirming that patients always retain the option to pursue in-office care instead of telehealth if they prefer a full physical examination.

What happens if MEDGm's technology fails during my appointment?

MEDGm's Terms of Use acknowledge that telehealth technology carries inherent risks, listing "interruptions, delays, unauthorized access, incomplete assessment... and missed or delayed diagnoses" among the disclosed possibilities, and confirming that either the patient or the Provider can choose to end an appointment if the technical connection proves inadequate for a proper visit. The brand's consent materials go further, noting that some of the technology used to deliver care, including AI-assisted tools, "may be used while still in a beta testing and development phase" and could contain bugs or errors that limit functionality or produce inaccurate records.

Get your MEDGm questions answered directly

MEDGm Buyer Verification Checklist

1. Confirm your state's specific consultation requirement (live video/phone vs. asynchronous) before starting intake.

2. Ask your assigned Provider for the exact medication cost if considering the Ozempic®, Wegovy®, or Zepbound® path, since membership fees are listed separately from medication cost.

3. Decide between a monthly plan and a multi-month bundle with the non-refundable bundle policy in mind.

4. Confirm which Pharmacy Partner is fulfilling your specific prescription and its shipping timeline.

5. Check with your HSA/FSA administrator about reimbursement eligibility before assuming coverage.

6. Confirm your actual next billing date before planning cancellation. MEDGm requires notice at least 72 hours before that billing date, and its Terms state billing and/or shipment may occur up to 10 days before the formal renewal date.

7. Read the full Consent to Compounded Medication before your first shipment, not after.

The Bottom Line on MEDGm

MEDGm is a cash-pay telehealth platform offering both compounded GLP-1 medication and a stated pathway to brand-name Ozempic®, Wegovy®, and Zepbound®, structured around three clearly named parties: the MEDGm platform itself, the licensed medical group OpenLoop Healthcare Partners, PC, and a rotating set of named compounding pharmacy partners. Pricing starts at $169 to $239 monthly for the compounded paths, with brand-name access priced as a separate membership fee plus an unlisted medication cost.

The brand publishes detailed disclosures covering the compounded-versus-brand-name distinction, boxed-warning language, and medical-disqualification refund provisions, published directly in MEDGm's Terms of Use and consent materials, which is where most of the source material for this article came from. What isn't fully disclosed publicly - the all-in cost of the brand-name paths, which specific pharmacy will fulfill a given order, and your individual clinical eligibility - gets resolved during the intake and consultation process, not on the marketing pages.

Anyone considering MEDGm should weigh the non-refundable subscription structure carefully, especially for multi-month bundles, and should read the compounded-medication consent language in full before the first shipment arrives.

MEDGm Contact Information

Per MEDGm's official pages reviewed for this article:

• Customer support email: support@medgm.org

• General notices email: info@medgm.org

• Legal notices email: legal@medgm.org

• Phone: +1 (214) 667-2145

• Registered office: MEDGm, LLC, 8 The Green, Suite R, Dover, DE 19901

• Official site: medgm.org

See if you qualify for MEDGm's GLP-1 program

Disclosure and Compliance Information

Material Limitations. This article is based on MEDGm's official website, Terms of Use, Cancellation and Refund Policy, Telehealth Consent, Safety Information, and Contact pages, all fetched directly from medgm.org, plus FDA.gov and California regulatory sources fetched directly for the regulatory-context and Proposition 65 sections. No product was tested and no clinical outcome was independently verified. Title language and brand claims are attributed to MEDGm and are not independently substantiated by this publication. Pricing, availability, and policy details reflect the brand's materials as reviewed in September 2026 and may have changed; confirm current terms directly with MEDGm before ordering. MEDGm publishes a detailed, medication-specific Safety Information page (medgm.org/safety-info) covering dosing schedules, contraindications, and drug interactions in more depth than this article addresses; readers considering enrollment should review it directly. The section on FDA's proposed 503B Bulks List exclusion reflects a proposed, not finalized, rule as of this article's writing - readers should check FDA.gov directly for any final determination, since this is an actively moving regulatory area. One minor sourcing note: MEDGm's general site-footer disclosure refers to its medical group simply as "OpenLoop Health," while the brand's Telehealth Consent page names the specific contracting legal entity as "OpenLoop Healthcare Partners, PC and its affiliated entities." Both sources point to the same medical group; this article uses the more specific entity name from the Telehealth Consent page. This article also documents several discrepancies between MEDGm's on-site FAQ (which uses expandable content not always visible to automated review tools on first pass) and its other published pages - including the BMI eligibility threshold, refund processing timing, and provider credentialing language - each noted where relevant rather than resolved on this publication's authority. The affiliate link in this article was not independently loadable by this publication's automated review tools at the time of writing due to the destination site's access restrictions; readers should independently confirm the link resolves as expected before relying on it, and are encouraged to verify current details directly on MEDGm's official site regardless.

Third-Party Feedback Platforms. No independent, third-party-audited review platform data was located on the MEDGm pages reviewed for this article - testimonials described here are brand-published and self-reported. The accuracy of third-party review platforms generally is not endorsed by this publication; such platforms should be evaluated critically by readers who encounter them elsewhere.

Forward-Looking Statements. This article reflects information available as of September 2026. Specifications, pricing, program structure, and policies described here may change at any time. Readers should rely on MEDGm's official site for current information rather than this article.

Marketing Language Notice. Phrases used in MEDGm's own marketing and referenced in this article - including "personalized care," "clear pricing," and similar promotional language - are brand-asserted marketing language, not independent rankings, lab-verified claims, or endorsements by this publication.

California Proposition 65 Notice. MEDGm's medications are dispensed by prescription through licensed pharmacies following a licensed provider's review - they are not sold as general retail consumer products. Under California law, prescription medications dispensed through a licensed provider's prescribing and informed-consent process are addressed differently from retail consumer products for Proposition 65 warning purposes (Cal. Code Regs., tit. 27, §25607.7(a); upheld in In re Vaccine Cases, 2005). California buyers with questions about Proposition 65 as it applies to their specific prescription should direct them to MEDGm or their prescribing provider directly.

Trademark Acknowledgment. MEDGm® and associated marks are property of their respective owner. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Zepbound® is a registered trademark of Eli Lilly and Company. All are referenced here for identification purposes only; per MEDGm's own disclosure, MEDGm is not affiliated with, endorsed by, or sponsored by any brand-name manufacturer, and this publication makes no independent claim of affiliation either.

Geographic and Jurisdiction Notice. MEDGm states it offers services in all 50 U.S. states and Washington, D.C., with availability subject to change and to vary by state; this article and the underlying offer are intended for U.S. residents only. International readers should confirm eligibility directly with the brand.

Medical Disclaimer. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate; approval is not guaranteed. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. This article does not provide medical advice and is not a substitute for consultation with a licensed healthcare provider. Individual results vary and are not guaranteed.

FTC Material Connection Disclosure. A commission is earned if a purchase is made through the affiliate links in this article. This does not increase the cost to the buyer.

SOURCE: MEDGm

Source: MEDGm